Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

PLX PHARMA INC.

(PLXP)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector news
All news about PLX PHARMA INC.
08/03PLX PHARMA : to Launch Vazalore in 8,000 CVS Stores in August
MT
08/02PLx Pharma Inc.'s VAZALORE to Launch in Nearly 8,000 CVS Stores this Month
GL
08/02PLx Pharma Inc.’s VAZALORE to Launch in Nearly 8,000 CVS Stores this Month
CI
07/27PLX PHARMA : to Make Vazalore Available in Over 2,400 Rite Aid Stores in August
MT
07/26PLX PHARMA : VAZALORE to Launch in Over 2,400 Rite Aid Stores in August
AQ
07/26PLx Pharma Inc.’s VAZALORE to Launch in Over 2,400 Rite Aid Stores in August
CI
07/22PLX PHARMA : to Discuss 2021 Second Quarter Financial Results on August 6, 2021 ..
AQ
07/20AFTER HOURS WATCH LIST SCORECARD : Plxp, ppg, ardx
MT
07/20PLx Shares Rise as Walgreens Set to Carry Vazalore in Stores
DJ
07/20SECTOR UPDATE : Health Care Stocks Edge Higher Pre-Bell Tuesday
MT
07/20PLX PHARMA : JMP Securities Adjusts PLx Pharma's Price Target to $21 From $12, K..
MT
07/19MT NEWSWIRES AFTER HOURS WATCH LIST : Plxp, ppg, ardx
MT
07/19PLX PHARMA : Shares Up 15% on VAZALORE's Walgreens Launch
MT
07/19PLx Pharma Inc.'s VAZALORE to Launch in over 8,000 Walgreens Stores Nationwid..
GL
07/15PLX PHARMA : Oppenheimer Adjusts PLx Pharma PT to $22 From $20, Maintains Outper..
MT
07/13AFTER HOURS WATCH LIST SCORECARD : Plxp, tyht, slp,
MT
07/13PLx Pharma Shares Up 30% as Vazalore Set To Launch in Walmart in August
DJ
07/13SECTOR UPDATE : Health Care Stocks Inch Lower Ahead of Tuesday Opener
MT
07/12MT NEWSWIRES AFTER HOURS WATCH LIST : Plxp, tyht, slp
MT
07/12PLX PHARMA : to Launch Liquid Aspirin Capsule Vazalore in Walmart Stores in Augu..
MT
07/12PLX PHARMA : VAZALORE to Launch in over 4,500 Walmart Stores Nationwide in Augus..
AQ
07/12Plx Pharma Inc.’s VAZALORE to Launch in over 4,500 Walmart Stores Nationwide ..
CI
06/09PLx Pharma Inc. to Present at Upcoming Healthcare Industry Conferences
GL
06/02Certain Series A Convertible Preferred Stock of PLx Pharma Inc. are subject t..
CI
06/02Certain Warrants of PLx Pharma Inc. are subject to a Lock-Up Agreement Ending..
CI
06/02Certain Series B Convertible Preferred Stock of PLx Pharma Inc. are subject t..
CI
06/02Certain Stock Appreciation Rights of PLx Pharma Inc. are subject to a Lock-Up..
CI
06/02Certain Restricted Stock Units of PLx Pharma Inc. are subject to a Lock-Up Ag..
CI
06/02Certain Stock Options of PLx Pharma Inc. are subject to a Lock-Up Agreement E..
CI
06/02Certain Common Stock of PLx Pharma Inc. are subject to a Lock-Up Agreement En..
CI
05/14PLX PHARMA : MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RES..
AQ
05/14Plx Pharma Inc. Reports Earnings Results for the First Quarter Ended March 31..
CI
05/14PLX PHARMA INC. : Results of Operations and Financial Condition, Financial State..
AQ
05/14PLx Pharma Inc. Reports First Quarter 2021 Results and Provides Business Upda..
GL
05/03PLx Pharma Inc. to Discuss 2021 First Quarter Financial Results on May 14, 20..
GL
04/09PLX PHARMA : Oppenheimer Initiates PLx Pharma at Outperform Rating With $20 Pric..
MT
03/17PLX PHARMA INC. : Other Events (form 8-K)
AQ
03/12PLX PHARMA INC. : Results of Operations and Financial Condition, Financial State..
AQ
03/12PLX PHARMA : MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RES..
AQ
03/12Plx Pharma Inc. Reports Earnings Results for the Fourth Quarter Ended Decembe..
CI
03/12PLx Pharma Inc. Reports Fourth Quarter and Full Year 2020 Results and Provide..
GL
03/11PLx Pharma Inc. to Present at the Oppenheimer 31st Annual Healthcare Conferen..
GL
03/04PLx Pharma Inc. to Discuss 2020 Fourth Quarter Financial Results on March 12,..
GL
03/03US Stocks End Lower as Tech Sector Retreats, Treasury Yields Continue Rise
MT
03/03CLOSE UPDATE : US Stocks End Lower as Tech Sector Retreats, Treasury Yields Cont..
MT
03/03PLX PHARMA INC. : Entry into a Material Definitive Agreement, Other Events, Fina..
AQ
03/03PLX PHARMA : Prices $63 Million Share Offering at Discount; Stock Drops 12%
MT
03/03MIDDAY REPORT : Wall Street Mixed Midday As Bond Yields Tick Up Again
MT
03/03PLx Pharma Inc. Prices $63 Million Underwritten Public Offering of Common Sto..
GL
03/02PLX PHARMA : Plans Common Stock Offering
MT
03/02PLX PHARMA INC. : Termination of a Material Definitive Agreement, Results of Ope..
AQ
03/02PLX PHARMA : Announces Proposed Public Offering of Common Stock
AQ
03/01PLX PHARMA : Secures FDA Approval for Vazalore Aspirin Therapy in Two Dose Stren..
MT
03/01PLX PHARMA : Corporate Presentation
PU
03/01PLX PHARMA INC. : Regulation FD Disclosure, Other Events, Financial Statements a..
AQ
03/01PLx Pharma Receives FDA Approval of SNDAs for Both VAZALORE 325 mg and 81 mg
GL
03/01PLx Pharma Receives FDA Approval of sNDAs for Both Vazalore 325 Mg and 81 Mg
CI
01/28PLX PHARMA : NAD Rejects Advertiser's Jurisdictional Argument That Claims Were D..
AQ
01/11PLX PHARMA INC. : Other Events, Financial Statements and Exhibits (form 8-K)
AQ
2020PLX PHARMA : Files Shelf of Up to About 10 Million Common Shares on Behalf of Se..
MT
2020PLX PHARMA INC. : Notice of Delisting or Failure to Satisfy a Continued Listing ..
AQ
2020PLx Pharma Inc. announced that it has received $18.008598 million in funding ..
CI
2020PLX PHARMA : Significant Insider purchase Extends the buy Trend of Last 90 Days ..
MT
2020INSIDER TRENDS : 90-Day Buying Trend Extended with Insider Purchase of Plx Pharm..
MT
2020PLX PHARMA INC. : Entry into a Material Definitive Agreement, Results of Operati..
AQ
2020PLX PHARMA : Swings to Q3 Loss
MT
2020PLx Pharma Inc. Reports Third Quarter 2020 Results and Provides Business Upda..
GL
2020PLX PHARMA : Reports Third Quarter 2020 Results and Provides Business Update
AQ
2020PLx Pharma Inc. Submits Supplemental New Drug Applications for VAZALORE&trade..
GL
2020PLX PHARMA : Submits Supplemental New Drug Applications for VAZALORE™ 325 ..
AQ
2020PLx Pharma Inc. Submits Supplemental New Drug Applications for VAZALOREÖ 325 ..
CI
2020PLx Pharma Inc. announced that it expects to receive $18.008598 million in fu..
CI
2020Plx Pharma Inc. Reports Earnings Results for the Third Quarter Ended Septembe..
CI
2020PLX PHARMA : MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RES..
AQ
2020PLX PHARMA : 2020 Third Quarter Financial Results and Business Update Conference..
AQ
1  2  3Next
Upcoming event on PLX PHARMA INC.
08/06/21